Later studies also found that G9a-like protein (GLP) and EZH2 work with G9a to catalyze the methylation of histone 3 lysine-residues in HNSCC, but there was no significant correlation between GLP, EZH2 and cisplatin sensitivity. Here, EZH2 is linked to head and neck squamous cell carcinoma.